Nautilus Biotechnology, Inc. (NAUT) Tops Q3 EPS by 4c

Nautilus Biotechnology, Inc. (NASDAQ: NAUT) reported Q3 EPS of ($0.11), $0.04 better than the analyst estimate of ($0.15).

For earnings history and earnings-related data on Nautilus Biotechnology, Inc. (NAUT) click here.

You May Also Be Interested In

• Corporación América Airports S.A. (CAAP) Misses Q2 EPS by 18c
• La-Z-Boy (LZB) Misses Q1 EPS by 6c, Misses on Revenue; Offers Weak Q2 Revenue Guidance
• Morgan Stanley Upgrades Honeywell Aerospace Inc (HONA) to Overweight